Category Archives: Corporate Responsibility

The Vanishing Rx Patient Assistance Programs?

by Tom Norton In the early 1990’s, during the debate over the Clinton healthcare plan, I recall sitting in an interesting meeting at my pharma company headquarters. In response to the Clinton’s charges that the industry was “price gouging,” my firm was proposing that we provide free prescription products to any patients who could not […]
Also posted in Guest Blog, healthcare, Legal, Market Access, Patient Communication | Tagged , , , , , , , | 1 Comment

Roche Jumps into Medicines Patent Pool with Pricing and Licensing Deal

Roche this week has announced a partnership with the UN-backed Medicines Patent Pool (MPP) to provide its drug valganciclovir, better known in the developed world as Valcyte, in 138 countries for a reduced price. In addition to making the drug available in these markets for up to 90% cheaper than current price, Roche has decided […]
Also posted in Deals, Emerging Markets, Global, IP, Market Access, pricing | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Compliance and Reporting: The Case for a Single System

by James Pierce Pharmaceutical companies are awash in a sea of compliance regulations that affect their business operations both inside and outside the US. This August, one more compliance wave will crest when the Physician Payments Sunshine Act (PPSA) begins requiring pharmaceutical companies to track and report virtually all payments to health care providers (HCPs). […]
Also posted in compliance, E-Media, Europe, FDA, Global, Guest Blog, Marketing, Regulatory, social media, Strategy, Technology | Tagged , , , , , , , | Leave a comment

Activism Is A Bitter Pill More Healthcare Companies May Have To Swallow

by Barbara Ryan In the next three months it is likely that three healthcare companies will face crucial activist votes.  At Alere Inc., Coppersmith Capital Management, LLC wants the company to sell/divest assets which it believes could allow them to pay down over $3B in debt.  In response, Alere is mounting a Hess style defense, […]
Also posted in Biotech, healthcare, leadership, Legal, Strategy | Tagged , , , , , , | Leave a comment

Five Compliance Questions to Ask Yourself, from the DOJ

At CBI’s 10th Annual Pharmaceutical Compliance Congress, Maame Ewusi-Mensah Frimpong, deputy assistant attorney general, consumer protection branch, civil division, at the US Department of Justice, said being compliant means understanding people, and their motivations. Frimpong said non-compliance boils down to a failure of individuals, and offered five questions for chief compliance officers to ask themselves […]
Also posted in compliance, leadership, Legal, Regulatory, Safety, Strategy | Tagged , , | Leave a comment
  • Categories

  • Meta